Table 5. Characteristics of the Risk Factors for the Presence of Stones with GB Polypoid Lesions (n=2378).
| Stone (n=119) | No stone (n=2259) | p value | |
|---|---|---|---|
| Overweight status* | 84 (70.6%) | 1270 (56.2%) | 0.002 |
| Fasting glucose (mg/dL)† | 95.0 (89.0–103.0) | 93.0 (87.0–100.0) | 0.051 |
| Total cholesterol (mg/dL) | 194.87±37.20 | 196.48±36.54 | 0.638 |
| TG (mg/dL)† | 104.0 (69.0–156.0) | 96.0 (63.0–146.0) | 0.159 |
| LDL cholesterol (mg/dL) | 121.13±33.63 | 123.08±32.38 | 0.523 |
| HDL cholesterol (mg/dL)† | 49.0 (43.0–56.0) | 49.0 (43.0–57.0) | 0.380 |
| Chronic hepatitis B | 4 (3.4%) | 117 (5.2%) | 0.381 |
| Chronic hepatitis C | 1 (0.8%) | 5 (0.2%) | 0.265 |
| Metabolic syndrome | 28 (23.5%) | 279 (12.4%) | <0.001 |
| Gastric HP infection | 25/39‡ (64.1%) | 282/607‡ (46.5%) | 0.032 |
| Colon polyp positive | 33/62§ (53.2%) | 548/992§ (55.2%) | 0.757 |
GB, gallbladder; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HP, Helicobacter pylori.
Data show median (P25–P75) or absolute number (%). The level of significance is set below 0.05.
*Overweight status: body mass index over 23 kg/m2, †Data are presented as median (P25–P75) and analyzed using the Mann-Whiteny U test due to abnormal distribution, ‡Data show positive/esophagogastroduodenoscopy patients, §Data show positive/colonoscopy patients.